3D Global Biotech Current Cash

3D Global Biotech (6808.TWO) currently reports a current cash of $30M as of June 2026. That compares with $55M in the prior-year period — down 45.3% year over year. Use the charts on this page to explore 3D Global Biotech's current cash history and peer comparisons.

3D Global Biotech's current cash decreased from $55M to $30M — a 45.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

3D Global Biotech reported $30M in current cash as of June 2026. That compares with $55M in the prior-year period — down 45.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $30M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 3D Global Biotech, and consider following 6808.TWO for alerts when major investors trade the stock.

3D Global Biotech is classified in the Healthcare sector. On current cash, it currently shows $30M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6808.TWO with unrelated industries.